The Boston-based Institute for Clinical and Economic Review (ICER), however, suggested a lower price range of around $2,520 to $2,800, if steroid dexamethasone were to be cleared for use in COVID-19. What Gilead could charge for remdesivir after its pledged donations are used up has been a topic of intense debate as millions of infections crop up across the country. …read more
Source:: Yahoo Finance
